2024. Exploring molecular docking strategies to target Cox-1 pain receptors with Caffeic Acid, Caftaric Acid, Alkyl Amide, and Indomethacin Ligands in the context of Fibromyalgia: A Pyrex software approach. Asian Journal of Pharmaceutical and Health Sciences. 14, 1 (Mar. 2024), 2940–2944.